Amphastar Pharmaceuticals (NASDAQ:AMPH) stock reached a 52-week low, trading at 22.6 USD. According to InvestingPro analysis, the company appears undervalued despite maintaining strong fundamentals ...

This research highlights the association between AMY1 gene copy number and salivary enzyme activity, with implications for ...